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Macro fungi are used as food and for therapy for centuries. One such fungus Lepista nuda (Bull.) Cooke is reported to 
exhibit many biological activities while other species viz. Lepista inversa and L. sordida possess active substances. In this 
study, we prepared extractions depended on polarity increase from the edible mushroom Lepista nuda and studied its action 
on HL60 (leukemia) and MCF7 (breast cancer) cancer cell lines., We used PCA (protocatechuic acid), paclitaxel and 
doxorubicin as positive controls. Methanol extract was found effective on both cell lines. The extract showed fairly 
significant (IC50 ~15 mg/mL) of biologic activity compared with drugs protocatechuic acid, paclitaxel and doxorubicin 
against HL-60 cell line with regard to both proliferation and apoptotic effects (>%75).  
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Cancer, as the leading cause of premature death to the 
tune of 10 million annually, affects the life 
expectancy of humans in every country. According to 
the Global Cancer Observatory (GLOBOCAN) 2020 
report of the International Agency for Research on 
Cancer, World Health Organization (WHO), 19.3 
million people are currently suffering from 36 types 
of cancers which is expected to rise to 28.4 million by 
20401. In Turkey, the number of new reported cases is 
0.23 million2. Globally, leukemia constitutes 2.6% of 
the toal new cases excluding nonmelanoma skin 
cancer, and breast cancer accounts for 12.5%. 
Worldwide, 0.68 million people have died due to 
breast cancer and 0.31 million by leukemia1. Such 
serious threat to human life by cancer makes 
accessibility of affordable treatment for population, a 
basic necessity. In this context, search for new 
anticancer drugs which are safe and economical has 
geared up.  
The identification of naturally occurring 
compounds in various living groups allows the 
discovery of new drugs or active substances which 
target cancer causing abnormal molecular and 
biochemical signals3-10. Apart from plants, mushrooms 
also serve as food supplements with their nutritional 
value and medicinal properties supporting human 
health11. These fungi show antioxidant, antimicrobial 
and antiviral properties12-17 Many fungal species have 
been studied by the researchers in terms of antioxidant 
content and antioxidant compounds and also have 
been identified in this context12,18,19. These are 
phenolic compounds, flavonoids, tocopherols, ascorbic 
acid and carotenoids20-22. Mushrooms have antioxidant 
properties and different flavours and attract both 
researchers and consumers in terms of these 
characteristics23,24. Mushrooms are also rich sources 
of anticancer compounds12,13,17,22,25-27.  
Lepista nuda 
Earlier researchers have reported useful bioactive 
constituents viz. phenolics (especially protocatechuic 
acid), tocopherols, ascorbic acid and carotenoids28-34 
and also alcohols, aldehydes, ketones, sesquiterpene-
like compounds and terpenes35 from mushrooms 
including Lepista nuda and also account for their 
antioxidant and antimicrobial effects28,34,35. The 
antioxidant capacity of methanol extract from L. nuda 
at 100 mg/mL concentration was found to be higher 
than the standard compounds at 400 mg/mL31. The 
linoleic acid inhibition value of L. nuda ethanol 
extract was found to be 84.3% (BHA: 98.9%, 
tocopherol: 99.2%) at a concentration of 160 μg/mL32. 
Methanol extract of Lepista inversa was found to be 
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effective in 4 cell lines (K562, U251, DU145, MCF7) 
compared with Taxol36. Lepista nuda mushroom 
extract tested on human cancer cells (HepG2, KATO 
III and AGS) inhibited proliferation of all three lines 
of cancer cells. The effect was strong between 0.5 and 
1.0 mg/mL in the range of 71.4 and 91.8%37. In 
Australia, ethanol, cold and hot water extracts 
obtained from 15 mushrooms including Lepista nuda, 
tested against normal mouse fibroblast cells 
(NIH/3T3), healthy human renal epithelial cells 
(HEK293) and 4 cancer cell lines (AGS, MDA-MB-
231, MCF7, HT29) using MTT method. Extract of 
Lepista nuda were found to be effective against 1 or 2 
cancer cell lines38. A new Metalloprotease isolated 
from Lepista nuda has been tested in hepatoma 
(HEPG2) and leukemia (L1210) cancer cell lines. IC50 
values were found to be 4.99 μM and 3.67 μM, 
respectively39. 
Lepista nuda is reported to contain active 
ingredients such as PCA (Protocatechuic acid), other 
phenolics, carotenoids and terpenes and will show 
biological activity against cancer cells. Here, we 
tested extracts from Lepista nuda mushroom on two 
cancer cell lines (HL60, MCF7) using MTT method 
to study the effects of antiproliferative activity and 
apoptosis. The results were compared with the known 
drugs paclitaxel and doxorubicin and with PCA 
(Protocatechuic acid) as active ingredient.  
 
Materials and Methods  
 
Mushroom material 
The mushroom Lepista nuda (Bull.) Cooke  
(Fam.: Tricholomataceae) was collected from the  
pine forest and open fields of Yerlisu köyü and 
Karatepe mevki, Keşan, EDİRNE, northwest of 
Turkey on 2nd and 3rd of November 2016. This 
mushroom was identified in the field survey on 
comparison with previously prepared herbarium 
samples. Taxonomic determination was made by  
Dr. Hakan ALLI from Muğla Sıtkı Koçman 
University. Voucher specimens, in duplicates were 
deposited in the herbarium of the Department of 
Biology, Aydın Adnan Menderes University. The 
others were stored at 80℃.  
 
Drying and extraction 
Mushrooms were freeze dried by lyophilisation, 
and then the material was milled; the obtained 
material was weighed and extracted in a solvent  
series of increasing polarity (petroleum ether, 
dichloromethane, ethyl acetate and methanol)40. 
Solvent was added 1:10, (e.g. 10 g material to 100 mL 
petroleum ether). After finishing the first extraction 
with petroleum ether, the obtained residues were 
filtered and the dried material was subjected 
sequentially to second extraction with dichloromethane, 
the third extraction with ethyl acetate, and fourth 
extraction with methanol. Extracts were prepared 
using soxhlet and rotary evaporator apparatus, which 
yielded dried extracts. 
 
Dissolving of extracts 
After evaporation of the solvents, the dried extracts 
were taken from the rotary evaporator and weighed. 
The amounts from the extracts, corresponding to 10 g 
dry weight of the mushroom (before extraction) were 
dissolved in 1.0 mL ethanol40. For proliferation assay, 
concentrations of 10, 20 and 40 mg/mL were used.  
 
Cell culture 
HL60 leukaemia cells and MCF7 breast cancer 
cells were purchased from ATCC. Cells were grown 
in RPMI 1640 and DMEM mediums supplemented 
with 10% heat inactivated fetal calf serum, 1%  
L-glutamine and 1% penicillin/streptomycin at 37℃ 
in a humidified atmosphere containing 5% CO2. All 
media and supplements were obtained from Life 
Technologies. Hoechst 33258 and propidium iodide 
were purchased from Sigma. 
 
Proliferation inhibition assay 
HL-60 and MCF-7 cells were seeded in 24-well 
plate at a concentration of 1×106 per mL and 
incubated with increasing concentrations of extracts 
(10, 20 and 40 mg/mL), drugs (doxorubicin 0.5 µM, 
paclitaxel 0.5 µM) and PCA (5 µM). Cell counts and 
IC50 values were determined for 48 h using MTT  
[3 (4,5-dimethyl thiazol 2 yl) 2,5-diphenyl tetrazolium 
bromide] staining assay. After 4 h incubating period 
with 5 mg/mL MTT-PBS staining solution, 150 µL of 
MTT solving solution were added per well. The OD 
values were measured using plate reader at 590 nm 
wavelength. Experiments were done in triplicate and 
the percentages of living cells were calculated as 
follows41-43. For control: mean OD control/mean 
OD control *100 =100%. For treatment: mean OD 
treatment/mean OD control *100= Living cells% 
 
Hoechst 33258 and propidium iodide double staining 
The Hoechst staining was performed according to 
the method described by Grusch et al.44. HL-60 and 
MCF-7 cells (1×106 per mL) were seeded in 24-well 
plate and incubated with 40 mg/mL concentration of 
extract, drugs (doxorubicin 0.5 µM, paclitaxel  




0.5 µM) and PCA (5 µM) for 48 h. Hoechst 33258 
and propidium iodide were added directly to the  
cells at final concentrations of 5 and 2 µg/mL, 
respectively. After 60 min of incubation at 37℃, cells 
were examined on Olympus BX51 fluorescence 
microscope equipped with a DAPI filter. Cells were 
photographed and analysed by visual examination 
(not by FACS). This method allows to distinguish 
between apoptosis and necrosis44,45. Cells were judged 
according to their morphology and the integrity of 
their cell membranes, which can easily be seen upon 
propidium iodide staining. 
 
Results and Discussion 
The study was carried out in two basic stages 
which determine the activity of inhibiting the 
proliferation and determining the apoptotic effect. In 
this context, extracts were obtained from collected 
fungi. Subsequent antiproliferative activities were 
determined using the HL60 human leukaemia cell line 
and MCF7 breast cancer cell line and concentration of 
the most effective extract type inhibiting 50% of the 
cells was selected. Apoptotic effects were determined 
with selected extract type. The findings of the study 
are presented below in the order listed above. 
 
Antiproliferative activity  
The proliferation data obtained as the result of 
experiments as detailed under methods are presented 
graphically in the Figs 1 and 2). Fig. 1, shows the 
effect of all the tested drugs and extracts in different 
concentrations against HL60 cell line. Doxorubicin 
and paclitaxel are well known cancer drugs and at 0.5 
µM these drugs have killed more than 50% of the 
cells. Also, PCA at 5 µM have destroyed more than 
50% of the cells. The best results with the mushroom 
extracts were obtained from ethyl acetate, 
dichloromethane and methanol solvents and these 
effects were found also statistically important. But 
they were effective at high concentrations. Only 
methanol extract wiped out more than 50% of cells 
between the 10 and 20 mg/mL concentration range. If 
compared with the known drugs and PCA the 
methanol extracts was found as the nearest active 
extract to the drugs and PCA. Therefore, it can be 
suggested that the active compounds of the mushroom 
can be dissolved in methanol better than the other 
solvents.  
Figure 2 shows the effects of all the tested drugs 
and extracts in different concentrations but differently 
against MCF7 cell line. Similarly, doxorubicin, 
paclitaxel and PCA destroyed more than 50% of  
the cells at applied concentrations. In MCF7 cell  
line results, the most effective extract type was  
found as methanol at the high concentration  
(40 mg/mL) and the effect was weaker than the effect 
on HL60 cell line. 
The next question was about how the cells died 
after application of drugs and extract types. The 
methanol extract proved to be the most effective 
extract type for comparing the cell death type between 
two cell lines HL60 and MCF7 the same 
concentration (40 mg/mL). In Fig. 3, we could 
 
Fig. 1 — Lepista nuda antiproliferative activity on HL-60 cell 
line. [Extracts of Lepista nuda mushrooms were applied in
increasing concentrations to HL-60 cells. Among the extracts
tested in the range of 10-40 mg/mL, the most effective was found
to be methanol extract. The IC50 value of the methanol extract was
calculated to be approximately 15 mg/mL] 
 
Fig. 2 — Lepista nuda antiproliferative activity on MCF-7 cell 
line. [Extracts of Lepista nuda mushrooms were applied in 
increasing concentrations to MCF-7 cells. Among the extracts 
tested in the range of 10-40 mg/mL, the most effective was found 
to be methanol extract. The IC50 value of the methanol extract was 
calculated to be approximately 40 mg/mL] 




observe apoptosis and necrosis ratios after 48 h 
application of the known drugs, PCA and 40 mg/mL 
methanol extracts in both cell lines. By comparison 
with the known drugs, the observed apoptosis ratios 
after extract application were found statistically 
important and especially the results of HL60 cell line 
showing significantly strong apoptotic effect of 
methanol extract.  
The cell lines studied by Bézivin et al.36 and our 
study here are the same. The MCF7 is used as a joint, 
while K562 is another leukemia cell line such as the 
HL60. In our study, the concentration that inhibited 
about 50% of the cells was 15 mg/mL for HL60 and 
40 mg/mL for MCF7 (Figs. 1 and 2). On the other 
hand, taxol was preferred as positive control by 
Bezivin et al.36 and it was found that Lepista inversa 
methanol extract was more effective in the treatment 
of cancer. Similarly, in our study, methanol extract 
was found to be more effective than doxorubicin and 
paclitaxel. Elmastaş et al.31, Bezivin et al.36 and 
Sanchez46 have reported that most of the compounds 
are obtained from the methanol extract of Lepista 
nuda. Furhter, Sanchez46 also reported the presence of 
β-carotene and α-tocopherol in the L. nuda methanol 
extract. Similarly, Elmastaş et al.31 have also obtained 
the antioxidant compounds from methanol extract of 
L. nuda.  
In this study, we used protocatechuic acid (PCA) as 
active ingredient. Barros et al.33 which analysed the 
flavonoids and phenolics contents of 16 different 
fungus species reported that Lepista nuda contains 
6.31 mg/g total phenolics and 33.47 mg of 
protocatechuic acid (PCA) in 1.0 kg dry material. 
PCA is reported to inhibit proliferation and have 
apoptotic effects on cancer cells. These effects of 
PCA have also been studied in human leukemia and 
human breast cancer cells. Tseng et al.47 studied the 
effects of PCA in human leukemia cells (HL60). 
Approximately, 50% of the cells died in 48 h and 
apoptotic effects were observed in 46.7% of the cells. 
In another study48, the apoptotic effect of PCA was 
determined in human breast cancer cells MCF7.  
Xie et al.49 revealed that PCA could modulate 
apoptosis and autophagy suggesting the potential of 
PCA for chemoprevention and chemotherapy of 
ovarian cancer.  
 
Apoptosis removes malignant or cancer cells from 
normal cells or tissue surrounding them without 
damage. Disorders in the function of apoptosis are 
common in many types of cancer and are resistant to 
treatment. Therefore, apoptosis pathways are the main 
targets for cancer treatment50. Fortin et al.51, isolated 
clitocin from Lepista inversa and tested in human 
cancer cell lines (DU145, K562, MCF7 and U251). 
They found clitocin to be effective in the 
concentration range of 185-578 nM. Further, the flow 
cytometric analysis revealed that clitocin antitumor 
activity was associated with apoptosis stimulation51. 
Although there are no studies on the apoptotic activity 
of Lepista nuda, the efficacy of the Lepista inversa 
active agent clitocin is a reference to our study. From 
Lepista sordida species a polysaccharide having a 
potent antitumor effect (LSPc1) was obtained. The 
anticancer activity and the mechanism of action of 
this substance were studied on laryngeal cancer 
(Hep2) cell line. The agent LSPc1 inhibited cell cycle 
by accumulating cells in G2/M phase within 48 hours. 
Additionally, apoptotic effects were observed 
morphologically and biochemically52. In this study, 
more than 75% apoptotic cells were observed, 
especially in the HL60 cell line for 48 h (Fig. 3). 
While the doxorubicin from the used positive 
controls, leads to cell death by necrosis, paclitaxel 
causes apoptosis. If compared as extract and pure 
drug the methanol extract was found to be more 
effective than paclitaxel on HL60 cell line and the act 
of mechanisms seems to be the same with PCA.  
 
 
Fig. 3 — Lepista nuda apoptotic activity on HL-60 and MCF-7 
cell lines. [The extract of Lepista nuda mushroom was applied to
HL-60 and MCF-7 cells at an effective concentration. According
to the results, necrosis was observed in very few levels. In the
MCF-7 cell line, the rate of necrosis was higher. However
necrosis was almost never observed in the HL-60 cell line. 
Apoptosis rates were high in both cell lines. The rates of apoptosis
in the HL-60 cell line were higher than those observed in the
MCF-7 cell line] 
 





When the results obtained from our study are 
evaluated together with literature data, it is obvious 
that there are compounds showing anticancer 
properties in Lepista fungi. Additionally, their 
activities on the cell lines are similar. The relevant 
active ingredients primarily stop the cell cycle; 
subsequently they induce stimulation of the apoptotic 
pathway. Morphological and biochemical results 
support this. Although there is not much work on this 
subject, in light of the data obtained from our study, it 
can be suggested that the compound or compounds 
found in Lepista nuda mushroom that are responsible 
for biological activity have the effect of stimulating 
apoptotic cell death together on HL60 and MCF7 cell 
lines. This activity is important in terms of molecular 
mechanisms targeted in cancer treatment approaches. 
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